Used in biomedical research to quantify levels of Heat Shock Protein 110 in cell lysates, tissue extracts, and biological fluids. Enables researchers to study the role of HSP-110 in cellular stress responses, protein folding, and immune modulation. Commonly applied in cancer research to evaluate HSP-110 expression in tumor cells and assess its potential as a biomarker or therapeutic target. Also utilized in immunology studies to investigate chaperone-mediated antigen presentation and immune activation. Provides a reliable, sensitive, and specific method for high-throughput screening in preclinical studies and drug development.